The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Big Pharma Split Corp stock forecast from 0 analysts, the average analyst target price for Big Pharma Split Corp is not available over the next 12 months. Big Pharma Split Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Big Pharma Split Corp is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Big Pharma Split Corp’s stock price was CAD 10.04. Big Pharma Split Corp’s stock price has changed by -0.10% over the past week, +2.14% over the past month and -0.10% over the last year.
No recent analyst target price found for Big Pharma Split Corp
No recent average analyst rating found for Big Pharma Split Corp
Company Overview Big Pharma Split Corp
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada. Read Less
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15...Read More
Frequently Asked Questions About Big Pharma Split Corp (PRM-PA:CA) Stock
Stock Target Advisor's fundamental analysis for Big Pharma Split Corp's stock is Bearish.
PRM-PA:CA stock's dividend yield is 5.09%.
Our analysis grades PRM-PA:CA stock's dividend yield at F. This means that PRM-PA:CA stock's dividend yield is above 32% of the stocks in the Asset Management sector in the TSX exchange.
Based on this PRM-PA:CA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on PRM-PA:CA's stock to indicate what its average analyst target is.
PRM-PA:CA stock's Price/Earning ratio is 3.08.
Our analysis grades PRM-PA:CA stock's Price / Earning ratio at C+. This means that PRM-PA:CA stock's Price/Earning ratio is above 21% of the stocks in the Asset Management sector in the TSX exchange.
Based on this PRM-PA:CA may be undervalued for its sector.
The last closing price of PRM-PA:CA's stock was CAD 10.04.
Unfortunately we do not currently have any market capitalization data for PRM-PA:CA's stock.
Unfortunately we do not have enough analyst data on PRM-PA:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Big Pharma Split Corp's stock.
As per our most recent records Big Pharma Split Corp has 0 Employees.
Big Pharma Split Corp's registered address is 610 Chartwell Road, Oakville, ON, Canada, L6j 4A5.
You can get more information about it from Big Pharma Split Corp's website at https://www.harvestportfolios.com/closed-end-funds.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PRM-PA:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
